NIFTY PHARMA (NIFTY PHARMA)
sectorActive threads
Sai Life Sciences Share Price: Sai Life soars 10%, hits record high on strong Q2 earnings
Sai Life soars 10%, hits record high on strong Q2 earnings Sai Life Sciences continues to expect a stronger second half, supported by the progression of the development and commercial pipeline and the ramp-up of new capacity.
PI Industries tanks 15%, hits 6-year low on disappointing Q2 results
PI Industries tanks 15%, hits 6-year low on disappointing Q2 results PI Industries said margins were impacted by higher input costs and pricing pressure due to El Nino & genericization. Listen to This Article PI Industries share price movement PI Industries' share price hit a six-year low of ₹1,859.25, plunging 15 per cent on the BSE in Thursday’s intraday deals in an otherwise strong market after the company reported disappointing September 2026 quarter (Q2FY27) results.
Emcure Pharma Q2 profit rises 29% YoY to Rs 325 crore
Emcure Pharma's Q2FY27 revenue rose 24.3% year-on-year to Rs 2,820.5 crore, while adjusted PAT climbed to Rs 325.1 crore from Rs 251.4 crore a year earlier. The growth was driven by a 34.5% year-on-year jump in international market revenue alongside domestic momentum, with EBITDA up 23.5% to Rs 587.3 crore at a flat 21% margin. The stock jumped 7% on the results before paring some gains.
Concord Biotech 1:1 bonus record date falls Wednesday
Only those shareholders who hold Concord Biotech shares in their demat accounts as of Wednesday will be eligible to receive the bonus shares. As per Sebi's T+1 settlement cycle, investors must buy the company's shares at least one trading day before the record date for them to be credited to their demat accounts and qualify for the bonus issue. This makes today the last day to buy the stock to be eligible for the bonus shares.
Laurus Labs hits 52-week high as Q2 profit jumps 126%
Laurus Labs shares surged 19% over four days and hit a 52-week high after Q2 profit jumped 126% year-on-year, with the stock up 111% year-to-date. The rally is being driven by strong CDMO momentum and the blowout quarterly results, which fueled fresh buying.
Intelligence feed· 1 article in 1440m
Sai Life Sciences Share Price: Sai Life soars 10%, hits record high on strong Q2 earnings
Story first reported.